Neurol. praxi. 2008;9(3):182-188

Antiepileptika a těhotenství

MUDr. Ivana Kacířová, doc. MUDr. Milan Grundmann, CSc.
Ústavklinické farmakologie FN a ZSF OU, Ostrava

Těhotenství může u některých pacientek s epilepsií zvyšovat frekvenci záchvatů. Jak epilepsie matky, tak expozice antiepileptické terapii in utero, mohou zvyšovat riziko poškození dítěte narozeného ženě s epilepsií. Přesto se při vhodné péči před otěhotněním, během těhotenství a po porodu narodí asi 90 % žen s epilepsií zdravé dítě. Epilepsie není kontraindikací těhotenství ani kojení. Cílem léčby antiepileptiky by měla být kontrola záchvatů bez závažných nežádoucích účinků.

Keywords: těhotenství, epilepsie, antiepileptika, záchvaty, vrozené defekty

Published: July 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kacířová I, Grundmann M. Antiepileptika a těhotenství. Neurol. praxi. 2008;9(3):182-188.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Adab N. Therapeutic monitoring of antiepileptic drugs during pregnancy and in the postpartum period. Is it useful? CNS Drugs 2006; 20(10): 791-800. Go to original source... Go to PubMed...
    2. Briggs GG, Freeman RK. Yaffe SJ. Drugs in pregnancy and lactation 7th edition. Lippincott Williams&Wilkins; 2005.
    3. Grundmann M, Zielinski M, Lickova R, Brozmanova H. TDM of antiepileptics during and after pregnancy. Ther Drug Monit 1995; 4: 405. Go to original source...
    4. Grundmann M. Změny farmakokinetiky v těhotenství a jejich klinický význam I. Interní Med. 2000; 3: 47-48.
    5. Jeha LE, Morris HH. Optimizing outcomes in pregnant women with epilepsy. Cleveland Clinic Journal of Medicine 2005; 10: 938-945. Go to original source... Go to PubMed...
    6. Kacirova I, Grundmann M, Koristkova B, Brozmanova H. Therapeutic monitoring of lamotrigine during delivery, in the neonatal period, and during lactation. Ther Drug Monit 2007; 4: 477.
    7. Kacirova I, Grundmann M, Koristkova B, Brozmanova H. Development of a Treatment of pregnant women with epilepsy between 1991 and 2006. Basic Clin Pharmacol Toxicol 2007; 101(Suppl. 1): 90.
    8. Kälviänen R, Tomson T. Optimizing treatment of epilepsy during pregnancy. Neurology 2006; 67(Suppl 4): 59-63. Go to original source... Go to PubMed...
    9. Meador KJ, Baker GA, Finnell RH, et al. In utero antiepileptic drug exposure. Fetal death and malformations. Neurology 2006; 67: 407-412. Go to original source... Go to PubMed...
    10. Neels HM, Sierens AC, Naelaerts K, et al. Therapeutic drug monitoring of old and newer antiepileptic drugs. Clin Chem Lab Med 2004; 42(11): 1228-1255. Go to original source... Go to PubMed...
    11. Pennell PB. Pregnancy in women who have epilepsy. Neurol Clin 2004; 22: 799-820. Go to original source... Go to PubMed...
    12. Penovich PE, Eck KE, Economou VV. Recommendations for the care of women with epilepsy. Cleveland Clinic Journal of Medicine 2004; 71(Suppl 2): 49-57. Go to original source... Go to PubMed...
    13. Pschirrer ER. Seizure disorders in pregnancy. Obstet Gynecol Clin N Am 2004; 31: 373-384. Go to original source... Go to PubMed...
    14. Samren EB, Van Duijn CM, Koch S, et al. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 1997; 38: 981-990. Go to original source... Go to PubMed...
    15. Syme MR, Paxton JW, Keelan JA. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet 2004; 43(8): 487-514. Go to original source... Go to PubMed...
    16. Thomas SV. Management of epilepsy and pregnancy. J Postgrad Med 2006; 1: 57-64.
    17. Tomson T. Gender aspects of pharmacokinetics of new and old AEDs. Pregnancy and breastfeeding. Ther Drug Monit 2005; 6: 718-721. Go to original source... Go to PubMed...
    18. Tomson T, Battino D. Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium. Clin Pharmacokinet 2007; 46(3): 209-219. Go to original source... Go to PubMed...
    19. Yerby MS, Kaplan PK, Tran T. Risks and management of pregnancy in women with epilepsy. Cleveland Clinic Journal of Medicine 2004; 71(Suppl 2): 25-37. Go to original source... Go to PubMed...
    20. Zárubová J. Terapie epilepsie v těhotenství. Moderní gynekologie a porodnictví 2004; 2: 222-229.

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.